These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9140510)

  • 81. Effects of Qinghaosu and chloroquine on the ultrastructure of the erythrocytic stage of P. falciparum in continuous cultivation in vitro.
    Ye ZG; Li ZL; Li GQ; Fu XQ; Liu HP; Gao MX
    J Tradit Chin Med; 1983 Jun; 3(2):95-102. PubMed ID: 6353081
    [No Abstract]   [Full Text] [Related]  

  • 82. Progress in the research of artemisinin and its analogues as antimalarials: an update.
    Sriram D; Rao VS; Chandrasekhara KV; Yogeeswari P
    Nat Prod Res; 2004 Dec; 18(6):503-27. PubMed ID: 15595609
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Plasmodium falciparum: in vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria.
    ter Kuile F; White NJ; Holloway P; Pasvol G; Krishna S
    Exp Parasitol; 1993 Feb; 76(1):85-95. PubMed ID: 8467901
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Association between Polymorphisms in the Pf
    Gendrot M; Diawara S; Madamet M; Kounta MB; Briolant S; Wade KA; Fall M; Benoit N; Nakoulima A; Amalvict R; Diémé Y; Fall B; Wade B; Diatta B; Pradines B
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052850
    [TBL] [Abstract][Full Text] [Related]  

  • 85. In vitro susceptibility of Tanzanian wild isolates of Plasmodium falciparum to artemisinin, chloroquine, sulfadoxine/pyrimethamine and mefloquine.
    Alin MH
    Parasitology; 1997 Jun; 114 ( Pt 6)():503-6. PubMed ID: 9172420
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Multiple dose pharmacokinetics of oral artemisinin and comparison of its efficacy with that of oral artesunate in falciparum malaria patients.
    Hassan Alin M; Ashton M; Kihamia CM; Mtey GJ; Björkman A
    Trans R Soc Trop Med Hyg; 1996; 90(1):61-5. PubMed ID: 8730315
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Efficacy of a 3-day oral regimen of quinine in an area of northern Nigeria with low-grade resistance of Plasmodium falciparum to chloroquine and sulphadoxine-pyrimethamine.
    Adagu SI; Okoyeh JN; Lege-Oguntoye L; Ogala WN; Ogunrinde GO; Faji JT; Sani AH
    J Trop Med Hyg; 1995 Oct; 98(5):296-8. PubMed ID: 7563254
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Response of Kampuchean strains of Plasmodium falciparum to antimalarials: in-vivo assessment of quinine and quinine plus tetracycline; multiple drug resistance in vitro.
    Giboda M; Denis MB
    J Trop Med Hyg; 1988 Aug; 91(4):205-11. PubMed ID: 3043009
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Antiplasmodial interactions between artemisinin and triclosan or ketoconazole combinations against blood stages of Plasmodium falciparum in vitro.
    Mishra LC; Bhattacharya A; Bhasin VK
    Am J Trop Med Hyg; 2007 Mar; 76(3):497-501. PubMed ID: 17360874
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The pharmacokinetics of artemisinin suppositories in Vietnamese patients with malaria.
    Koopmans R; Duc DD; Kager PA; Khanh NX; Dien TK; de Vries PJ; van Boxtel CJ
    Trans R Soc Trop Med Hyg; 1998; 92(4):434-6. PubMed ID: 9850402
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Artemisinin kinetics and dynamics during oral and rectal treatment of uncomplicated malaria.
    Ashton M; Nguyen DS; Nguyen VH; Gordi T; Trinh NH; Dinh XH; Nguyen TN; Le DC
    Clin Pharmacol Ther; 1998 Apr; 63(4):482-93. PubMed ID: 9585803
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Aminoindoles, a novel scaffold with potent activity against Plasmodium falciparum.
    Barker RH; Urgaonkar S; Mazitschek R; Celatka C; Skerlj R; Cortese JF; Tyndall E; Liu H; Cromwell M; Sidhu AB; Guerrero-Bravo JE; Crespo-Llado KN; Serrano AE; Lin JW; Janse CJ; Khan SM; Duraisingh M; Coleman BI; Angulo-Barturen I; Jiménez-Díaz MB; Magán N; Gomez V; Ferrer S; Martínez MS; Wittlin S; Papastogiannidis P; O'Shea T; Klinger JD; Bree M; Lee E; Levine M; Wiegand RC; Munoz B; Wirth DF; Clardy J; Bathurst I; Sybertz E
    Antimicrob Agents Chemother; 2011 Jun; 55(6):2612-22. PubMed ID: 21422215
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Clinical pharmacokinetics and pharmacodynamics of artemisinin and derivatives.
    White NJ
    Trans R Soc Trop Med Hyg; 1994 Jun; 88 Suppl 1():S41-3. PubMed ID: 8053024
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Artemisinin pharmacokinetics is time-dependent during repeated oral administration in healthy male adults.
    Ashton M; Hai TN; Sy ND; Huong DX; Van Huong N; Niêu NT; Công LD
    Drug Metab Dispos; 1998 Jan; 26(1):25-7. PubMed ID: 9443848
    [TBL] [Abstract][Full Text] [Related]  

  • 95. In vitro evidence for auto-induction of artemisinin metabolism in the rat.
    Gupta S; Svensson US; Ashton M
    Eur J Drug Metab Pharmacokinet; 2001; 26(3):173-8. PubMed ID: 11695717
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Susceptibility of Pneumocystis carinii to artemisinin in vitro.
    Merali S; Meshnick SR
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1225-7. PubMed ID: 1929266
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Quantitative in vivo and in vitro sex differences in artemisinin metabolism in rat.
    Ashton M; Johansson L; Thornqvist AS; Svensson US
    Xenobiotica; 1999 Feb; 29(2):195-204. PubMed ID: 10199595
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Altering Antimalarial Drug Regimens May Dramatically Enhance and Restore Drug Effectiveness.
    Kay K; Hodel EM; Hastings IM
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6419-27. PubMed ID: 26239993
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Artemisinin resistance in Plasmodium falciparum: A process linked to dormancy?
    Cheng Q; Kyle DE; Gatton ML
    Int J Parasitol Drugs Drug Resist; 2012 Dec; 2():249-255. PubMed ID: 23420506
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Artemisinin‐induced dormancy in plasmodium falciparum: duration, recovery rates, and implications in treatment failure.
    Teuscher F; Gatton ML; Chen N; Peters J; Kyle DE; Cheng Q
    J Infect Dis; 2010 Nov; 202(9):1362-8. PubMed ID: 20863228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.